VERONA PHARMA PLC's ticker is VRNA and the CUSIP is 925050106. A total of 41 filers reported holding VERONA PHARMA PLC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,473,589 | -29.7% | 335,803 | -8.9% | 0.00% | – |
| Q2 2023 | $7,791,358 | +11.7% | 368,560 | +6.1% | 0.00% | – |
| Q1 2023 | $6,972,298 | -22.7% | 347,226 | +0.6% | 0.00% | – |
| Q4 2022 | $9,023,343 | – | 345,325 | +2656246.2% | 0.00% | – |
| Q3 2022 | $0 | – | 13 | 0.0% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 13 | -100.0% | 0.00% | – |
| Q3 2021 | $1,346,000 | -17.7% | 245,594 | -1.7% | 0.00% | – |
| Q2 2021 | $1,635,000 | – | 249,941 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 2,457,499 | $16,932,000 | 5.79% |
| Aisling Capital Management LP | 1,332,485 | $9,327,000 | 1.60% |
| Ghost Tree Capital, LLC | 810,000 | $5,670,000 | 1.26% |
| Vivo Capital, LLC | 3,048,507 | $21,340,000 | 0.95% |
| NEA Management Company, LLC | 5,108,563 | $35,760,000 | 0.94% |
| Novo Holdings A/S | 2,608,755 | $18,261,000 | 0.78% |
| Samsara BioCapital, LLC | 1,111,112 | $7,778,000 | 0.78% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,033,603 | $7,235,000 | 0.64% |
| RA Capital Management | 5,100,000 | $31,824,000 | 0.44% |
| Orbimed Advisors | 5,694,841 | $39,864,000 | 0.35% |